Related references
Note: Only part of the references are listed.TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation
Shirong Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Stopping a thief and killer: Alzheimer's disease crisis demands greater commitment to research
William Thies
ALZHEIMERS & DEMENTIA (2011)
Impact of P-Glycoprotein Inhibition and Lipopolysaccharide Administration on Blood-Brain Barrier Transport of Colistin in Mice
Liang Jin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: Multiplex quantification with path analysis
Michelle A. Erickson et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Neuronal Death Induced by Nanomolar Amyloid β Is Mediated by Primary Phagocytosis of Neurons by Microglia
Urte Neniskyte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Amyloid-β peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier
Masachika Fujiyoshi et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide
Andrej Kovac et al.
JOURNAL OF NEUROINFLAMMATION (2011)
From the Liver to the Blood-Brain Barrier: An Interconnected System Regulating Brain Amyloid-β Levels
Abhay P. Sagare et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Peripheral Reduction of β-Amyloid Is Sufficient To Reduce Brain β-Amyloid: Implications for Alzheimer's Disease
J. Gregor Sutcliffe et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
RESTRAINT STRESS AND REPEATED CORTICOTROPHIN-RELEASING FACTOR RECEPTOR ACTIVATION IN THE AMYGDALA BOTH INCREASE AMYLOID-β PRECURSOR PROTEIN AND AMYLOID-β PEPTIDE BUT HAVE DIVERGENT EFFECTS ON BRAIN-DERIVED NEUROTROPHIC FACTOR AND PRE-SYNAPTIC PROTEINS IN THE PREFRONTAL CORTEX OF RATS
B. Ray et al.
NEUROSCIENCE (2011)
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Hasini C. Wijesuriya et al.
BRAIN RESEARCH (2010)
The Role of Cerebral Vascular NF kappa B in LPS-induced Inflammation: Differential Regulation of Efflux Transporter and Transporting Cytokine Receptors
Weihong Pan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease Implications for Aβ accumulation in AD brain
Joshua B. Owen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
A Physiological Role for Amyloid-beta Protein: Enhancement of Learning and Memory
John E. Morley et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Apical-to-Basolateral Transport of Amyloid-beta Peptides through Blood-Brain Barrier Cells is Mediated by the Receptor for Advanced Glycation End-Products and is Restricted by P-Glycoprotein
Pietra Candela et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay
Brian T. Hawkins et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain
Berislav V. Zlokovic et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease
Anika M. S. Hartz et al.
MOLECULAR PHARMACOLOGY (2010)
Molecular inflammation: Underpinnings of aging and age-related diseases
Hae Young Chung et al.
AGEING RESEARCH REVIEWS (2009)
Lipopolysaccharide alters the blood-brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer's disease
Laura B. Jaeger et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Peripheral Amyloid-beta Levels Regulate Amyloid-beta Clearance from the Central Nervous System
Marcos A. Marques et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-Brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
Laura B. Jaeger et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Lipopolysaccharide Impairs Blood-Brain Barrier P-glycoprotein Function in Mice Through Prostaglandin- and Nitric Oxide-Independent Pathways
Mohamad A. Salkeni et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Erin G. Reed-Geaghan et al.
JOURNAL OF NEUROSCIENCE (2009)
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Robert D. Bell et al.
NATURE CELL BIOLOGY (2009)
Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death
Rohini Polavarapu et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells
Kaoru Yamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
γ-Secretase Limits the Inflammatory Response Through the Processing of LRP1
Kai Zurhove et al.
SCIENCE SIGNALING (2008)
Multiplicity of cerebrospinal fluid functions: New challenges in health and disease
Conrad E. Johanson et al.
FLUIDS AND BARRIERS OF THE CNS (2008)
Lipoprotein receptor-related protein-1 mediates amyloid-β-mediated cell death of cerebrovascular cells
Micha M. M. Wilhelmus et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Cerebral clearance of human amyloid-β peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes
Shingo Ito et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
Robert D. Bell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment
D. Allan Butterfield et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease
John E. Donahue et al.
ACTA NEUROPATHOLOGICA (2006)
Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid β-peptide by the liver
Chihiro Tamaki et al.
PHARMACEUTICAL RESEARCH (2006)
Rapid modulation of p-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-α and lipopolysaccharide
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2006)
The critical component to establish in vitro BBB model: Pericyte
CH Lai et al.
BRAIN RESEARCH REVIEWS (2005)
The choroid plexus removes β-amyloid from brain cerebrospinal fluid
JS Crossgrove et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2005)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloidβ protein 40 in wild-type and Alzheimer's disease transgenic mice (APP, PS1) and its implications for amyloid plaque formation
KK Kandimalla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Mouse syngenic in vitro blood-brain barrier model:: a new tool to examine inflammatory events in cerebral endothelium
C Coisne et al.
LABORATORY INVESTIGATION (2005)
Puromycin-based purification of rat brain capillary endothelial cell cultures.: Effect on the expression of blood-brain barrier-specific properties
N Perrière et al.
JOURNAL OF NEUROCHEMISTRY (2005)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Systemic catabolism of Alzheimer's Aβ40 and Aβ42
J Ghiso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice
JG Sheng et al.
NEUROBIOLOGY OF DISEASE (2003)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: Impairment in a mouse model of Alzheimer's disease
WA Banks et al.
NEUROSCIENCE (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Phosphorylation of LRP1: Regulation of transport and signal transduction
P van der Geer
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Amyloid-β:: An antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease
A Kontush
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Protective effect of vitamin E, β-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide
AA Kheir-Eldin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
